Medical Research
Global Alliance For Tb Drug Development Inc
NEW YORK, NY
Total revenue
$63.7M
Total expenses
$61.5M
Net assets
$176.3M
Grants received
$74.5M
19 grants
EIN
134128413
Tax year
2024
Mission
To accelerate the discovery & development of new drugs to facilitate the control of tuberculosis throughout the world and the accessibility of these drugs to the global community.
Programs
2 programs
Public affairs and policy - tb alliance maintains critical alliances with public and private organizations to raise awareness about tuberculosis ("tb") and advocate for public and private involvement in research for the public good. Specifically, tb alliance negotiates terms that support the development and access of new affordable anti-tb drugs equitably for those areas most in need while encouraging the private sector on the development of these medicines. Tb alliance continues to pursue an explicit commitment to our "aaa mandate" - that all new products will be adopted, available and affordable to those with tb.
Business development - tb alliance negotiates, implements and manages agreements with public and private organizations worldwide and does so by adhering to sound business practices while ensuring the public good. Specifically, tb alliance negotiates terms that support the development and access of new affordable anti-tb drugs equitably to those areas most in need while encouraging the private sector to help develop new medicines for tb indications.
Financials
FY 2024
Revenue
Expenses
People
23 listed
DR MELVIN SPIGELMAN
PRESIDENT/CEO
$940K
45 hrs/wk
COLLEEN PERO
SECRETARY/CAO
$470K
45 hrs/wk
ANGELA VANDERPLOEG
TREASURER/CFO
$422K
45 hrs/wk
SUNDAR KODIYALAM
DIRECTOR
—
3 hrs/wk
DAVID NORTON
CHAIR
—
3 hrs/wk
AKSHAY VAISHNAW
DIRECTOR (AS OF 12/01/24)
—
3 hrs/wk
ANN TAYLOR
DIRECTOR (AS OF 09/01/24)
—
3 hrs/wk
ERIC GOOSBY
DIRECTOR
—
3 hrs/wk
KIM SCHWARTZ
DIRECTOR
—
3 hrs/wk
MITCHELL WARREN
DIRECTOR
—
3 hrs/wk
RASHA HIBRI
DIRECTOR
—
3 hrs/wk
RATAN WATAL
DIRECTOR
—
3 hrs/wk
SRISHTI GUPTA
DIRECTOR (AS OF 12/01/24)
—
3 hrs/wk
ARIEL PABLOS-MENDEZ
VICE-CHAIR
—
3 hrs/wk
DR EUGENE SUN
SR. VP, RESEARCH & DEVELOPMENT
$581K
45 hrs/wk
DR NADER FOTOUHI
SR. VP, CHIEF SCIENTIFIC OFFICER
$565K
45 hrs/wk
MARIA BEUMONT
VP, CHIEF MEDICAL OFFICER
$498K
45 hrs/wk
ROBERT LORETTE
SR. VP, BUSINESS DEVELOPMENT
$449K
45 hrs/wk
KATHLEEN SCHOSTACK
SR. VP, PROGRAM & ALLIANCE MANAGEMENT
$432K
45 hrs/wk
SALAH FORAIDA
SR. DIRECTOR, MEDICAL AFFAIRS
$430K
45 hrs/wk
SANDEEP JUNEJA
SR. VP, MARKET ACCESS
$418K
45 hrs/wk
RAJNEESH TANEJA
VP, PHARMACEUTICAL PRODUCT DEVELOPMENT
$371K
45 hrs/wk
PIETRO O TURILLI
SR. VP, EXTERNAL AFFAIRS
$369K
45 hrs/wk
Independent contractors
PPD DEVELOPMENT LP
GLOBAL CRO
WUXI APPTEC (HONGKONG) LIMITED
INTEGRATED R&D SERVICES
CERBA RESEARCH NV
LAB COSTS
CLININVENT RESEARCH PVT LTD
DRUG MANUFACTURING / TESTING
GLAXOSMITHKLINE INVESTIGACION
EXTERNAL MINI PORTFOLIOS
Grants received
Showing 19 of 19
Funded by
$74.5M from 5 funders · 19 grants · 2017–2024
$72.9M · 12 grants · 2020–2024
$1.5M · 2 grants · 2017–2020
$30K · 3 grants · 2022–2024
$8K · 1 grant · 2017
$8K · 1 grant · 2023